pharmaphorum3d
A history of Novartis
In 2003, Novartis acquired the worldwide adult medical nutrition business of Mead Johnson and Company, which is a subsidiary of Bristol-Myers Squibb, and also US biotech Idenix Pharmaceuticals ...
Bristol-Myers Squibb: Too Valuable Not To Hold This Pharma Gem, But Debt Challenges Remain
Bristol-Myers Squibb gets rated a hold, as I see future value in its clinical portfolio and pipeline, particularly ...
Bristol Myers’ Breyanzi receives positive CHMP opinion in follicular lymphoma
Bristol Myers (BMY) announced the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, has ...
Bristol Myers price target raised to $65 from $60 at Citi
Citi raised the firm’s price target on Bristol Myers (BMY) to $65 from $60 and keeps a Neutral rating on the shares. Ahead of the Q4 earnings, ...
Nasdaq3d
See Which Of The Latest 13F Filers Holds Bristol Myers Squibb
In terms of shares owned, we count 4 of the above funds having increased existing BMY positions from 09/30/2024 to 12/31/2024, with 2 having decreased their positions and 4 new positions.
Morningstar1d
Bristol-Myers Squibb Co
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Bristol Post5d
Hospital responds to shocking claims of ‘never events’ in patient safety row
North Bristol NHS Trust (NBT) has refuted claims suggesting high numbers of foreign items are being left inside patients, including cannulas, which were accidentally left in one patient's body ...